|
|
1)
|
chain |
A |
residue |
93 |
type |
|
sequence |
Q
|
description |
binding site for residue TAR A 301
|
source |
: AC1
|
|
2)
|
chain |
A |
residue |
97 |
type |
|
sequence |
D
|
description |
binding site for residue TAR A 301
|
source |
: AC1
|
|
3)
|
chain |
A |
residue |
131 |
type |
|
sequence |
L
|
description |
binding site for residue TAR A 301
|
source |
: AC1
|
|
4)
|
chain |
A |
residue |
139 |
type |
|
sequence |
D
|
description |
binding site for residue TAR A 301
|
source |
: AC1
|
|
5)
|
chain |
A |
residue |
56 |
type |
|
sequence |
R
|
description |
binding site for Di-peptide GLU D0 155 and TPO D0 156
|
source |
: AC6
|
|
6)
|
chain |
A |
residue |
129 |
type |
|
sequence |
R
|
description |
binding site for Di-peptide GLU D0 155 and TPO D0 156
|
source |
: AC6
|
|
7)
|
chain |
A |
residue |
130 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide GLU D0 155 and TPO D0 156
|
source |
: AC6
|
|
8)
|
chain |
A |
residue |
175 |
type |
|
sequence |
N
|
description |
binding site for Di-peptide GLU D0 155 and TPO D0 156
|
source |
: AC6
|
|
9)
|
chain |
A |
residue |
178 |
type |
|
sequence |
V
|
description |
binding site for Di-peptide GLU D0 155 and TPO D0 156
|
source |
: AC6
|
|
10)
|
chain |
A |
residue |
222 |
type |
|
sequence |
L
|
description |
binding site for Di-peptide GLU D0 155 and TPO D0 156
|
source |
: AC6
|
|
11)
|
chain |
A |
residue |
226 |
type |
|
sequence |
N
|
description |
binding site for Di-peptide GLU D0 155 and TPO D0 156
|
source |
: AC6
|
|
12)
|
chain |
A |
residue |
56 |
type |
|
sequence |
R
|
description |
binding site for Di-peptide TPO D0 156 and GLN D0 157
|
source |
: AC7
|
|
13)
|
chain |
A |
residue |
122 |
type |
|
sequence |
K
|
description |
binding site for Di-peptide TPO D0 156 and GLN D0 157
|
source |
: AC7
|
|
14)
|
chain |
A |
residue |
129 |
type |
|
sequence |
R
|
description |
binding site for Di-peptide TPO D0 156 and GLN D0 157
|
source |
: AC7
|
|
15)
|
chain |
A |
residue |
130 |
type |
|
sequence |
Y
|
description |
binding site for Di-peptide TPO D0 156 and GLN D0 157
|
source |
: AC7
|
|
16)
|
chain |
A |
residue |
175 |
type |
|
sequence |
N
|
description |
binding site for Di-peptide TPO D0 156 and GLN D0 157
|
source |
: AC7
|
|
17)
|
chain |
A |
residue |
218 |
type |
|
sequence |
L
|
description |
binding site for Di-peptide TPO D0 156 and GLN D0 157
|
source |
: AC7
|
|
18)
|
chain |
A |
residue |
41-51 |
type |
prosite |
sequence |
RNLLSVAYKNV
|
description |
1433_1 14-3-3 proteins signature 1. RNLLSVAYKNV
|
source |
prosite : PS00796
|
|
19)
|
chain |
A |
residue |
56 |
type |
SITE |
sequence |
R
|
description |
Interaction with phosphoserine on interacting protein
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
20)
|
chain |
A |
residue |
129 |
type |
SITE |
sequence |
R
|
description |
Interaction with phosphoserine on interacting protein
|
source |
Swiss-Prot : SWS_FT_FI1
|
|
21)
|
chain |
A |
residue |
5 |
type |
MOD_RES |
sequence |
S
|
description |
Phosphoserine => ECO:0007744|PubMed:20068231
|
source |
Swiss-Prot : SWS_FT_FI2
|
|
22)
|
chain |
A |
residue |
74 |
type |
MOD_RES |
sequence |
S
|
description |
Phosphoserine => ECO:0007744|PubMed:23186163
|
source |
Swiss-Prot : SWS_FT_FI3
|
|